The HrC Test Has a Landmark Week with Global Recognition and Expansion
This week is shaping up to be a significant milestone for the HrC test, a revolutionary innovation in early cancer risk assessment developed by Tzar Labs. This ground-breaking blood test is designed to detect a wide range of cancers at their earliest stages, providing a significant advantage over current diagnostic technologies. Get ready for a whirlwind of achievements as the HrC test takes centre stage at a global conference, receives a prestigious award, and launches a new state-of-the-art laboratory!
Showcasing the HrC test at the SIP-BILANZ Health and Longevity Conference
We’re excited to announce that the HrC test will be presented at the highly anticipated SIP-BILANZ Health and Longevity Conference in Zurich on April 3, 2025. This inaugural conference, held at the Park Hyatt Zurich, will focus on the most critical topics in preventive medicine and longevity. The event will explore strategies and products aimed at extending healthy lifespans, covering a wide range of areas, including preventive health management, addiction, dementia, health insurance, longevity science, and advancements in key medical fields like cardiology.
The conference’s emphasis on proactive healthcare solutions and the science of longevity makes it the perfect platform to introduce the HrC test to an audience deeply invested in these areas. The SIP-BILANZ conference attracts leading experts from healthcare, science, and business, creating an ideal environment for knowledge sharing and potential collaborations. Notably, previous SIP conferences have drawn high-net-worth individuals and their advisors, a demographic with a strong interest in cutting-edge health and longevity solutions. The partnership between SIP Medical Family Office and BILANZ, a prominent Swiss business magazine, further extends the reach to business leaders and potential investors. This conference provides unparalleled access to key opinion leaders and a discerning audience eager to discover the latest breakthroughs in extending healthy lives.
Here are the key details of the conference:
- Date: April 3, 2025
- Time: 9:00 AM – 7:00 PM (CET)
- Location: Park Hyatt Zurich, Switzerland
- Key Themes: Preventive health management, addiction, dementia, health insurance and related financial planning, longevity science, assisted death, latest healthcare advancements (cardiology, etc.)
Global Recognition: HrC Test Receives Prestigious Edison Award
In more exciting news, the HrC test has been honoured with the esteemed Edison Award! The Edison Awards celebrate excellence in innovation, recognising ground-breaking products and services across various industries. This annual competition highlights innovations that demonstrate excellence in new product and service development, marketing, human-centred design, and overall innovation. Winners are acknowledged for their “game-changing” impact and leadership in innovation, evaluated based on rigorous criteria including:
- Concept: Opportunity, conception, method & development
- Value: Need/desire, differentiation, advantage & cost
- Delivery: Message, engagement, availability, achievement
- Impact: Sustainability, social responsibility & potential
The HrC test has been named a finalist in the “Health, Medical, & Biotech” category, acknowledging its significant advancements and potential impact in the healthcare sector. This recognition from the Edison Awards signifies that the HrC test has undergone a thorough evaluation process, meeting high standards of innovation and demonstrating its potential to address critical needs in healthcare. Receiving this prestigious award will significantly elevate the profile of the HrC test in the global healthcare arena. This global recognition underscores the transformative potential of the HrC test and its commitment to advancing the field of early cancer detection.
The HrC Test: Expanding Reach and Capacity in the UK
To top off this incredible week, we’re thrilled to announce the opening of our new laboratory in London on April 7th. Located at Artisan Court, Market Way, Wembley, HA0 2BT, this facility represents a significant expansion of our operational capabilities in the United Kingdom.
The opening of the London laboratory marks a significant milestone in Tzar Labs’ commitment to making the HrC test widely available in the UK. This expansion demonstrates our dedication to improving cancer diagnosis by detecting the disease at its earliest stages, with the goal of increasing the chances of successful treatment. Our vision is to utilise this technology to significantly reduce deaths caused by late cancer diagnoses and shift the paradigm towards early intervention. The establishment of this advanced facility underscores our ambition to potentially integrate the HrC test into national cancer screening programs, making this innovative risk assessment tool accessible to a broader population in the UK.
A Word from Our Leadership
“This is a truly momentous week for the HrC test,” says Steve Smith, UK Business Development Director at Tzar Labs. “The presentation at the SIP-BILANZ conference allows us to share our innovative approach with a global audience of experts, while the Edison Award validates the ground-breaking nature and potential impact of our technology. The opening of our new laboratory in London is the culmination of years of hard work and signifies our commitment to bringing this potentially life-saving test to more people in the UK.”